[1]
“Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)”, Reumatismo, vol. 60, no. 4, pp. 290–295, Dec. 2008, doi: 10.4081/reumatismo.2008.290.